We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Upper Tribunal Administrative Appeals Chamber decision by Judge Church on 29 April 2024
This guide is to help you and your business understand how to ensure that content on your service is appropriate for children.
Disclosure and Barring service (DBS) guidance about making referrals. Also includes information about relevant offences.
Low Pay Commission publishes advice to Government on the future of the National Minimum Wage beyond 2024
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
This guide is to help you and your business understand how to protect children from sexual exploitation and abuse on your platform.
Description of UKHSA adult surveillance programmes for COVID-19.
How catch limits are set and how to get involved in setting them. This includes current catch limits and closed fishing areas.
Sets out the rules that apply to ESFA funded AEB provision for the 2021 to 2022 funding year.
Release of statistics on the reoffending of adults under probation supervision.
The Ministry of Defence cadet forces provide a challenging and stimulating contemporary cadet experience that develops and inspires young people within a safe environment.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Offending behaviour programmes and interventions currently available for offenders in England and Wales.
Upper Tribunal Administrative Appeals Chamber decision by Judge Wright on 7 February 2024.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).